Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lane

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Psychopharmacology|December 6, 2000
Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatmentJ R Walker, M A Van Ameringen, R Swinson, et al.
The American Journal of Psychiatry|February 7, 2001
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled studyM A Van Ameringen, R M Lane, J R Walker, et al.
Cell Death & Disease|April 17, 2015
BCL-2 is dispensable for thrombopoiesis and platelet survivalM A Debrincat, I Pleines, M Lebois, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Psychopharmacology|December 6, 2000
Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatmentJ R Walker, M A Van Ameringen, R Swinson, et al.
The American Journal of Psychiatry|February 7, 2001
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled studyM A Van Ameringen, R M Lane, J R Walker, et al.
Cell Death & Disease|April 17, 2015
BCL-2 is dispensable for thrombopoiesis and platelet survivalM A Debrincat, I Pleines, M Lebois, et al.
Pageof 3